European Union - English - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidone palmitate - schizophrenia - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.1).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - orodispersible tablet - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - orodispersible tablet - 3mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - oral tablet - 3mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - oral tablet - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - methylphenidate hydrochloride - modified-release tablet - 27mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - miconazole nitrate - cutaneous cream - 20mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - oxybutynin hydrochloride - modified-release tablet - 5mg

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - oxybutynin hydrochloride - tablet prolonged release - 10 milligram - oxybutynin

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - oxybutynin hydrochloride - tablet prolonged release - 5 milligram - oxybutynin